ClinicalTrials.Veeva

Menu

Clinical Evaluation of Different Potassium Oxalate Concentrations in Dentin Hypersensitivity Treatment

F

Federal University of Uberlandia

Status

Unknown

Conditions

Dentine Hypersensitivity
Dentin Sensitivity
Hypersensitivity Dentin
Dentin Hypersensitivity

Treatments

Drug: Potassium Oxalate 5%
Drug: Potassium Oxalate 10%

Study type

Interventional

Funder types

Other

Identifiers

NCT03083496
61102016.0.0000.5152

Details and patient eligibility

About

This study aims to evaluate the longevity and efficacy of two products potassium oxalate-basedin two concentrations, 10% and 5%, by triple randomized blind clinical trial (split-mouth) . The desensitization approach (single agent) and the long-term effectiveness (baseline, 1 week, 2 weeks, 3 weeks). Data will be collected, tabulated and submitted to statistical analysis.

Full description

Dentin hypersensitivity (DH) is characterized as a short, intense and sudden pain caused by thermal, chemical and evaporative stimuli. There are several types of desensitizing agents, used to aid in the control of this pathology, but they are not very effective and have short longevity. The agents based on potassium oxalate have been used by dental surgeons because they have mixed action, both neural and obliterating. Therefore, the aim of this study is through a triple blind randomized clinical trial (split-mouth), evaluate the longevity and efficacy of two products potassium oxalate-based in two concentrations, 10% and 5%. Thirty-two with DH at least 2 teeth and adequate oral hygiene will be randomly divided into two different groups according to the desensitization approach (10% and 5%) The dentin hypersensitivity level will be evaluated immediately after desensitization and after 1, 2 and 3. Data will be collected, tabulated and submitted to statistical analysis.

Enrollment

32 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Healthy individuals
  • Both genres, interested in the treatment of Dentin Hypersensitivity
  • Patients with all teeth in their mouth
  • Patients who have at least three teeth with Dentin hypersensitivity in different quadrants
  • Good oral hygiene

Exclusion criteria

  • Caries or unsatisfactory restorations
  • Presence of periodontal disease and or parafunctional habits
  • Cracks or enamel fractures
  • Extensive or unsatisfactory restorations
  • Recent restorations involving the labial surface
  • Pulpitis
  • Dentures
  • Orthodontics
  • Smokers
  • Pregnant women
  • Gastroesophageal disease presence
  • Uncontrolled systemic disease
  • Severe bruxism
  • Constant use of analgesic
  • Allergic response to dental products

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

32 participants in 2 patient groups

Potassium Oxalate 5%
Active Comparator group
Description:
Prophylaxis of the teeth; an application every 48 hours; 4 sessions
Treatment:
Drug: Potassium Oxalate 5%
Drug: Potassium Oxalate 10%
Potassium Oxalate 10%
Active Comparator group
Description:
Prophylaxis of the teeth; an application every 48 hours; 4 sessions
Treatment:
Drug: Potassium Oxalate 5%
Drug: Potassium Oxalate 10%

Trial contacts and locations

1

Loading...

Central trial contact

Paulo V Soares, DDS,MS,PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems